Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02747017 · ClinicalTrials.gov registry record
Observational Study of C. Diff in Post-Transplant Patients
A clinical trial, sponsored by University of Minnesota.
- Completed
- Registry status
- 132
- Enrollment target
NCT02747017: Completed study, sponsored by University of Minnesota.
NCT02747017 is a clinical trial that has completed, run by University of Minnesota. The registered enrollment target is 132 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT02747017 has completed, sponsored by University of Minnesota.
- COMPLETED
- Registry status
- 132 participants
- Enrollment target
Study Summary
The primary objective of this observational study is to estimate the 90-day response rates to treatment for a first episode of C. difficile infections (CDI) in adult transplant recipients.
Primary Outcome
The planned first course of CDI treatment was completed with resolution of symptoms or less than 3 loose stools per day for at least two consecutive days maintained until end of treatment and two days after treatment course ended.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 132 participants |
| Start Date | 2016-08-22 |
| Est. Completion | 2018-10-30 |
What the finished NCT02747017 record still lists
NCT02747017 is an observational study that tracks outcomes without assigning an intervention. The registered 132 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 0 interventions.
NCT02747017 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT02747017 about?
NCT02747017 is a clinical study titled "Observational Study of C. Diff in Post-Transplant Patients". The primary objective of this observational study is to estimate the 90-day response rates to treatment for a first episode of C. difficile infections (CDI) in adult transplant recipients.
What is the current status of trial NCT02747017?
This trial is currently completed. The enrollment target is 132 participants. The study started on 2016-08-22. Estimated completion is 2018-10-30.
Who is sponsoring clinical trial NCT02747017?
This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01766297 · 132 participants · Phase 2
Phase II Protocol of Proton Therapy for Partial Breast Irradiation in Early Stage Breast Cancer
- NCT04002947 · 132 participants · Phase 2
Acalabrutinib With DA-EPOCH-R or R-CHOP for People With Untreated Diffuse Large B-cell Lymphoma
- NCT04128189 · 132 participants · Phase 3
Shingrix in Renal Transplant Recipients
- NCT04199780 · 132 participants · NA
Effects of tDCS Combined With CBI on Postsurgical Pain
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI